184 related articles for article (PubMed ID: 9517289)
1. [Mixed uterine mesodermal sarcoma in the population of southern Israel in the years 1996-1971--clinical and pathological characteristics].
Ariad S; Rabinovitz A; Yanai-Inbar I; Piura B
Harefuah; 1998 Jan; 134(2):93-6, 159. PubMed ID: 9517289
[TBL] [Abstract][Full Text] [Related]
2. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
Le T; Krepart GV; Lotocki RJ; Heywood MS
Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
[TBL] [Abstract][Full Text] [Related]
3. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
[TBL] [Abstract][Full Text] [Related]
4. Malignant mixed mesodermal tumors of the ovary.
DiSilvestro PA; Gajewski WH; Ludwig ME; Kourea H; Sung J; Granai CO
Obstet Gynecol; 1995 Nov; 86(5):780-2. PubMed ID: 7566848
[TBL] [Abstract][Full Text] [Related]
5. [Sarcomas and mixed mesodermal tumors of the uterus].
Günthert AR
Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
[TBL] [Abstract][Full Text] [Related]
6. [Synchronous growth of a mixed mesodermal tumor and an adenocarcinoma of the urinary bladder].
Heimbach D; Dämmrich J; Wirth M; Frohmüller H
Urologe A; 1993 Nov; 32(6):451-4. PubMed ID: 8284854
[TBL] [Abstract][Full Text] [Related]
7. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
[TBL] [Abstract][Full Text] [Related]
8. Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus.
Nguyen CP; Levi AW; Montz FJ; Bristow RE
Gynecol Oncol; 2000 Dec; 79(3):499-503. PubMed ID: 11104628
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
[TBL] [Abstract][Full Text] [Related]
10. [Mixed mesodermal tumor of the uterine body].
Inoue S; Munemura M; Nakayama M; Maeyama M; Tokunaga T
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):967-74. PubMed ID: 6308110
[TBL] [Abstract][Full Text] [Related]
11. [Mixed mesodermal tumors of the uterus. Clinico-pathologic characteristics of 23 patients].
Ostojić NS; Vujanić GM; Sretenović Z; Dojcinov D
Srp Arh Celok Lek; 1992; 120(3-4):127-31. PubMed ID: 1334577
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous endometrial malignant mixed mesodermal tumor and ovarian serous adenocarcinoma.
Krigman HR; Coogan AC; Marks JR
Arch Pathol Lab Med; 1995 Jan; 119(1):99-103. PubMed ID: 7802567
[TBL] [Abstract][Full Text] [Related]
13. [Malignant mixed mesodermal tumors of the ovary: a clinical analysis of 12 cases].
Li H; Shi S; Zhang W
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):460-2. PubMed ID: 10920946
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma.
Tanga R; Delgado G
Int Surg; 1982; 67(4):339-44. PubMed ID: 7160994
[TBL] [Abstract][Full Text] [Related]
15. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
17. Mixed mesodermal tumor of the uterine body: relationship between histology and survival.
Sakamoto A; Sugano H
Gan; 1976 Apr; 67(2):263-73. PubMed ID: 184005
[TBL] [Abstract][Full Text] [Related]
18. [Uterine mixed malignant mesodermal tumors--a case with an unusual distribution of components].
Zámecník M
Cesk Patol; 1993 Dec; 29(4):147-9. PubMed ID: 8313481
[TBL] [Abstract][Full Text] [Related]
19. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.
Marth C; Windbichler G; Petru E; Dirschlmayer W; Obermair A; Czerwenka K; Müller-Holzner E; Dapunt O
Gynecol Oncol; 1997 Jan; 64(1):121-5. PubMed ID: 8995559
[TBL] [Abstract][Full Text] [Related]
20. The increasing trend in Japan of müllerian mixed tumor of endometrium.
Kato T; Teshima S; Watanabe S; Yamada T; Tanemura K; Tsunematsu R; Ohmi K; Sonoda T; Kasamatsu T; Kishi K
Jpn J Clin Oncol; 1988 Dec; 18(4):303-8. PubMed ID: 2849692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
